FSRH | COC – risks of different oestrogen and progesterone

22nd July 2016 by Louise Hudman

FSRH | COC – risks of different oestrogen and progesterone

This is a statement from the FSRH on a study recently published on risks with COC use. This study looks at how the different dose of oestrogen and how the different progesterone affect the risk of PE, CVA and MI. Bottom line – we should be advising women choosing the COC that a 20mcg ethinylestradiol/levonorgestrel pill may have lower thrombotic risks (though there is no such pill available in the UK at present).

The study showed that:

  • levonorgestrel containing pills have a lower risk of PE than desogestrel and gestodene containing pills.
  • 20mcg ethinylestradiol containing pills have a lower risk of PE, ischaemic CVA and MI than pills containing more oestrogen.

How significant is this?

The results are significant. However, the absolute levels of risk are low and the study didn’t look at the background risks in the population.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


"Joining NASGP's Locum Chambers in Essex after CCT has been a fantastic decision for me. The Chambers structure provides support with my locum work as well as a peer support network with regular meetings.

The Chambers support also extends to support with complaints when these occur. This is an amazing benefit that helps to minimise the professional isolation that can come with being a locum.

The Instant Book feature within LocumDeck makes arranging sessions easy. Whilst getting things set up initially does take a bit of work, this eventually pays off and the return on this initial time investment is impressive. New features are always being added based on feedback from members. "

Dr Shanil Shivji, GP, Essex

See the full list of features within our NASGP membership plans